同德化工(002360) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the period was ¥300,577,057.70, representing a 6.06% increase year-over-year[7]. - Net profit attributable to shareholders decreased by 11.68% to ¥49,080,488.45 compared to the same period last year[7]. - The net profit after deducting non-recurring gains and losses was ¥56,633,539.39, up 5.67% year-over-year[7]. - The company's operating revenue for the current period is CNY 69,325,393.18, a decrease from CNY 73,512,405.10 in the previous period, representing a decline of approximately 5.4%[41]. - The net profit for the current period is CNY 59,696,504.86, compared to CNY 11,899,575.71 in the previous period, indicating a significant increase[42]. - The net profit attributable to the parent company's owners is CNY 94,342,410.94, down from CNY 126,957,319.97, indicating a decrease of about 25.7%[47]. - The comprehensive income total for the current period is CNY 119,979,616.30, compared to CNY 71,534,065.05 in the previous period, showing an increase of approximately 67.7%[47]. Assets and Liabilities - Total assets increased to ¥1,670,579,571.84, up 11.58% from the previous year[7]. - Current assets as of September 30, 2020, total CNY 991.27 million, an increase from CNY 832.44 million at the end of 2019[27]. - The company's total assets reached CNY 1.67 billion, up from CNY 1.50 billion at the end of 2019, indicating a growth of about 11.5%[28]. - Total liabilities increased to CNY 407.16 million from CNY 311.80 million, representing a rise of approximately 30.5%[29]. - The company's equity attributable to shareholders increased to CNY 1.20 billion from CNY 1.14 billion, showing a growth of about 5.9%[30]. - The total liabilities amounted to ¥311,800,723.14, reflecting the company's financial obligations[63]. - The total assets of the company were reported at ¥1,497,196,190.19, indicating the overall scale of the company's operations[63]. - The company's total liabilities were reported at CNY 384,133,874.97 as of September 30, 2020[69]. Cash Flow - Cash flow from operating activities was ¥41,141,732.66, a slight increase of 2.21%[7]. - Cash flow from operating activities generated a net amount of ¥59,778,479.05, down 36.00% from ¥93,467,236.98 in the same quarter last year[54]. - The net cash flow from operating activities was -¥70,500,931.72, a significant decrease compared to ¥63,917,779.72 in the previous period, indicating a decline in operational performance[56]. - Cash inflow from investment activities was ¥22,846,424.81, down from ¥119,256,849.45 in the previous year[55]. - The company reported a total cash outflow from operating activities of ¥241,116,393.00, which is significantly higher than ¥124,518,737.49 in the previous period[56]. - The cash and cash equivalents at the end of the period amounted to ¥168,341,115.78, down from ¥198,787,530.54, showing a decrease in liquidity[58]. Investment and Financing - The total amount raised from the convertible bond issuance is CNY 144.28 million, which will be invested in the construction of a production line for 12,000 tons of gel emulsified explosives and 11,000 tons of powder emulsified explosives, an information technology platform, and debt restructuring[19]. - The balance of the raised funds account is CNY 77.42 million, which is reserved for subsequent expenditures related to the investment projects[19]. - The company reported investment income of CNY 50,000,000.00 for the current period, a notable increase from CNY 10,608.59 in the previous period[41]. - The company received ¥50,000,000.00 in investment income, a substantial increase from ¥5,675,358.59 in the previous period, highlighting improved investment returns[56]. - Total cash inflow from financing activities reached ¥227,172,528.93, up from ¥112,500,000.00 in the previous period, reflecting increased financing efforts[58]. Research and Development - Research and development expenses increased significantly to ¥6,691,139.57 from ¥2,230,250.46, highlighting a commitment to innovation[37]. - Research and development expenses increased to CNY 2,943,639.29 from CNY 2,230,250.46, reflecting a growth of approximately 32%[41]. - Research and development expenses for the quarter were ¥5,964,170.52, slightly up from ¥5,420,929.98 in the previous year[49]. Other Financial Metrics - The weighted average return on equity was 4.17%, down 1.01% from the previous year[7]. - Earnings per share for the third quarter were ¥0.13, compared to ¥0.14 in the previous year[39]. - Basic earnings per share for the current period is CNY 0.25, down from CNY 0.33 in the previous period, indicating a decrease of approximately 24.2%[47]. - Financial expenses for the period amounted to ¥4,096,200, an increase of 1154.33% due to higher bond interest expenses[15]. - Financial expenses rose significantly to CNY 4,096,206.67 from CNY 326,566.56, reflecting a substantial increase[46].